Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.

Noninvasive imaging is used for many different (pre)clinical purposes, ranging from disease diagnosis, disease staging, and treatment monitoring to the visualization and quantification of nanomedicine-mediated drug targeting and (triggered) drug release. Noninvasive imaging can be employed to visualize and quantify how efficient passive or active drug targeting is in individual patients and, on this basis, to preselect patients likely to respond to nanomedicine-based chemotherapeutic interventions. In addition, it can be used to visualize the off-target localization of nanomedicines, e.g., in potentially endangered healthy tissues, which under certain circumstances might lead to exclusion from targeted treatment. Moreover, by systematically integrating imaging also during follow-up and by closely monitoring therapeutic responses upon nanomedicine treatment, clinical decision making can be facilitated and improved, as decisions on whether or not to (dis)continue treatment and on whether or not to adjust drug doses can be made relatively early on. Noninvasive imaging may be particularly useful in the case of metastatic disease. By subsequently performing PET or SPECT scans with radionuclide-labeled nanomedicines, information can be obtained on the accumulation of these formulations in both primary tumors and metastases, and treatment protocols can be adapted accordingly.

[1]  F. Kiessling,et al.  Image-guided drug delivery: preclinical applications and clinical translation , 2015, Expert opinion on drug delivery.

[2]  F. Kiessling,et al.  Water-soluble dopamine-based polymers for photoacoustic imaging. , 2015, Chemical communications.

[3]  R. Boellaard,et al.  89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied? , 2015, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[4]  Richard Su,et al.  Melanin nanoparticles as a novel contrast agent for optoacoustic tomography , 2015, Photoacoustics.

[5]  Vasilis Ntziachristos,et al.  Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT). , 2015, Biomaterials.

[6]  H. Hong,et al.  Matching the Decay Half-Life with the Biological Half-Life: ImmunoPET Imaging with 44Sc-Labeled Cetuximab Fab Fragment , 2014, Bioconjugate chemistry.

[7]  Wei Huang,et al.  Transferring Biomarker into Molecular Probe: Melanin Nanoparticle as a Naturally Active Platform for Multimodality Imaging , 2014, Journal of the American Chemical Society.

[8]  Valerie A Longo,et al.  A Modular Labeling Strategy for In Vivo PET and Near-Infrared Fluorescence Imaging of Nanoparticle Tumor Targeting , 2014, The Journal of Nuclear Medicine.

[9]  O. Thews,et al.  18F-Radiolabeling, preliminary evaluation of folate-pHPMA conjugates via PET. , 2014, Macromolecular bioscience.

[10]  R. Schibli,et al.  Promising Prospects for 44Sc-/47Sc-Based Theragnostics: Application of 47Sc for Radionuclide Tumor Therapy in Mice , 2014, The Journal of Nuclear Medicine.

[11]  R. Weissleder,et al.  18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Enables the Detection of Recurrent Same-Site Deep Vein Thrombosis by Illuminating Recently Formed, Neutrophil-Rich Thrombus , 2014, Circulation.

[12]  E. Ahrens,et al.  Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI , 2014, Magnetic resonance in medicine.

[13]  Chris Jun Hui Ho,et al.  Multifunctional Photosensitizer-Based Contrast Agents for Photoacoustic Imaging , 2014, Scientific Reports.

[14]  Hanno Schieferstein,et al.  Radiolabeling of Nanoparticles and Polymers for PET Imaging , 2014, Pharmaceuticals.

[15]  V. Ntziachristos,et al.  Polyglycerolsulfate Functionalized Gold Nanorods as Optoacoustic Signal Nanoamplifiers for In Vivo Bioimaging of Rheumatoid Arthritis , 2014, Theranostics.

[16]  T. Kenny,et al.  CORRIGENDUM: Quantum Limit of Quality Factor in Silicon Micro and Nano Mechanical Resonators , 2014, Scientific Reports.

[17]  Fabian Kiessling,et al.  Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines. , 2014, Nano letters.

[18]  M. A. van den Bosch,et al.  The effects of Magnetic Resonance Imaging-guided High-Intensity Focused Ultrasound ablation on human cadaver breast tissue. , 2013, European journal of pharmacology.

[19]  Anne Bol,et al.  Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice. , 2013, Contrast media & molecular imaging.

[20]  Lorena Petrusca,et al.  Experimental methods for improved spatial control of thermal lesions in magnetic resonance-guided focused ultrasound ablation. , 2013, Ultrasound in medicine & biology.

[21]  Klaas Nicolay,et al.  Paramagnetic liposomes for molecular MRI and MRI‐guided drug delivery , 2013, NMR in biomedicine.

[22]  Klaas Nicolay,et al.  The evolution of MRI probes: from the initial development to state‐of‐the‐art applications , 2013, NMR in biomedicine.

[23]  Sheung Tat Fan,et al.  High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients. , 2013, World journal of gastroenterology.

[24]  M. S. Walsum,et al.  Inert coupling of IRDye800CW and zirconium-89 to monoclonal antibodies for single- or dual-mode fluorescence and PET imaging , 2013, Nature Protocols.

[25]  G. V. van Dongen,et al.  Pilot Study on the Feasibility of PET/CT Lymphoscintigraphy with 89Zr-Nanocolloidal Albumin for Sentinel Node Identification in Oral Cancer Patients , 2013, The Journal of Nuclear Medicine.

[26]  Ralph Weissleder,et al.  Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques , 2013, Circulation research.

[27]  Vasilis Ntziachristos,et al.  Vaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancer , 2013, Proceedings of the National Academy of Sciences.

[28]  G. V. van Dongen,et al.  89Zr-PET radiochemistry in the development and application of therapeutic monoclonal antibodies and other biologicals. , 2013, Current topics in medicinal chemistry.

[29]  Fabian Kiessling,et al.  Noninvasive optical imaging of nanomedicine biodistribution. , 2013, ACS nano.

[30]  K. Nicolay,et al.  Multifunctional magnetic resonance imaging probes. , 2013, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[31]  K. Ulbrich,et al.  HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[32]  A. Alavi,et al.  Emerging optical and nuclear medicine imaging methods in rheumatoid arthritis , 2012, Nature Reviews Rheumatology.

[33]  Robert Carlisle,et al.  Ultrasound-enhanced drug delivery for cancer , 2012, Expert opinion on drug delivery.

[34]  M. V. van Zandvoort,et al.  Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[35]  F. Kiessling,et al.  Personalized Nanomedicine , 2012, Clinical Cancer Research.

[36]  Enzo Terreno,et al.  Image guided therapy: the advent of theranostic agents. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[37]  F. Kiessling,et al.  Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[38]  F. Roesch,et al.  Scandium-44: benefits of a long-lived PET radionuclide available from the (44)Ti/(44)Sc generator system. , 2012, Current radiopharmaceuticals.

[39]  Sanjiv S Gambhir,et al.  Family of enhanced photoacoustic imaging agents for high-sensitivity and multiplexing studies in living mice. , 2012, ACS nano.

[40]  Levon M Khachigian,et al.  DNAzyme Targeting c-jun Suppresses Skin Cancer Growth , 2012, Science Translational Medicine.

[41]  Lixin Lang,et al.  Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. , 2012, Biomaterials.

[42]  V. Ntziachristos,et al.  FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography–X-ray computed tomography , 2012, Nature Methods.

[43]  J. A. Hendricks,et al.  Synthesis of [18F]BODIPY: bifunctional reporter for hybrid optical/positron emission tomography imaging. , 2012, Angewandte Chemie.

[44]  Robert Langer,et al.  Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.

[45]  Fabian Kiessling,et al.  Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics , 2012, The Journal of Nuclear Medicine.

[46]  F. Kiessling,et al.  Theranostic systems and strategies for monitoring nanomedicine-mediated drug targeting. , 2012, Current pharmaceutical biotechnology.

[47]  G. V. van Dongen,et al.  Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy , 2012, Molecular Cancer Therapeutics.

[48]  Jesse V. Jokerst,et al.  A Brain Tumor Molecular Imaging Strategy Using A New Triple-Modality MRI-Photoacoustic-Raman Nanoparticle , 2011, Nature Medicine.

[49]  Fabian Kiessling,et al.  Theranostic nanomedicine. , 2020, Accounts of chemical research.

[50]  R. Weissleder,et al.  89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. , 2011, Bioconjugate chemistry.

[51]  Young Ha Kim,et al.  Highly selective in-vivo imaging of tumor as an inflammation site by ROS detection using hydrocyanine-conjugated, functional nano-carriers. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[52]  R. Duncan,et al.  Nanomedicine(s) under the microscope. , 2011, Molecular pharmaceutics.

[53]  Jesse V Jokerst,et al.  Molecular imaging with theranostic nanoparticles. , 2011, Accounts of chemical research.

[54]  F. Kiessling,et al.  Macromolecular nanotheranostics for multimodal anticancer therapy. , 2011, Nanoscale.

[55]  P. Choyke,et al.  Near infrared fluorescence‐guided real‐time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green , 2011, International journal of cancer.

[56]  W. Roos,et al.  89Zr-Nanocolloidal Albumin–Based PET/CT Lymphoscintigraphy for Sentinel Node Detection in Head and Neck Cancer: Preclinical Results , 2011, The Journal of Nuclear Medicine.

[57]  P. Low,et al.  Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.

[58]  D. Jaffray,et al.  APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[59]  Dong Liang,et al.  Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts. , 2011, Biomaterials.

[60]  Srirang Manohar,et al.  Gold nanorods as molecular contrast agents in photoacoustic imaging: the promises and the caveats. , 2011, Contrast media & molecular imaging.

[61]  Chen Jiang,et al.  Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis. , 2011, Biomaterials.

[62]  J. A. Hendricks,et al.  In vivo PET imaging of histone deacetylases by 18F-suberoylanilide hydroxamic acid (18F-SAHA). , 2011, Journal of medicinal chemistry.

[63]  Jan E Schnitzer,et al.  Overcoming in vivo barriers to targeted nanodelivery. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[64]  Stephen Meairs,et al.  Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[65]  G. V. van Dongen,et al.  (89)Zr-labeled compounds for PET imaging guided personalized therapy. , 2011, Drug discovery today. Technologies.

[66]  S. Emelianov,et al.  Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance. , 2011, Trends in biotechnology.

[67]  A. Louie,et al.  Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging. , 2011, Bioconjugate chemistry.

[68]  R. Weissleder,et al.  High‐Yielding, Two‐Step 18F Labeling Strategy for 18F‐PARP1 Inhibitors , 2011, ChemMedChem.

[69]  Ashish Ranjan,et al.  Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound , 2011, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[70]  N. Hijnen,et al.  Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[71]  R. Weissleder,et al.  In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation , 2011, Nature Medicine.

[72]  R. Weissleder,et al.  Synthesis and in vivo imaging of a 18F-labeled PARP1 inhibitor using a chemically orthogonal scavenger-assisted high-performance method. , 2011, Angewandte Chemie.

[73]  S. Emelianov,et al.  Silica-coated gold nanorods as photoacoustic signal nanoamplifiers. , 2011, Nano letters.

[74]  N. Warde Imaging: PET–CT Promising in animal studies , 2011, Nature Reviews Rheumatology.

[75]  Daniel A. Heller,et al.  Treating metastatic cancer with nanotechnology , 2011, Nature Reviews Cancer.

[76]  Roel Deckers,et al.  Ultrasound triggered, image guided, local drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[77]  F. Rösch,et al.  72/74As-labeling of HPMA based polymers for long-term in vivo PET imaging. , 2010, Bioorganic & medicinal chemistry letters.

[78]  I. Jacobs,et al.  Noninvasive visualization of in vivo release and intratumoral distribution of surrogate MR contrast agent using the dual MR contrast technique. , 2010, Biomaterials.

[79]  Klaas Nicolay,et al.  Block-copolymer-stabilized iodinated emulsions for use as CT contrast agents. , 2010, Biomaterials.

[80]  Zibo Li,et al.  Theranostic agents that co-deliver therapeutic and imaging agents? , 2010, Advanced drug delivery reviews.

[81]  A. S. Moses,et al.  Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.

[82]  Jin Xie,et al.  Nanoparticle-based theranostic agents. , 2010, Advanced drug delivery reviews.

[83]  Feng Gao,et al.  In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. , 2010, ACS nano.

[84]  V. Ntziachristos Going deeper than microscopy: the optical imaging frontier in biology , 2010, Nature Methods.

[85]  Alexander L. Vahrmeijer,et al.  Optical Image-guided Surgery—Where Do We Stand? , 2010, Molecular Imaging and Biology.

[86]  Manojit Pramanik,et al.  Sentinel lymph nodes in the rat: noninvasive photoacoustic and US imaging with a clinical US system. , 2010, Radiology.

[87]  C. Moonen,et al.  Ultrasound-triggered image-guided therapy , 2010 .

[88]  E. Terreno,et al.  In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[89]  Fabian Kiessling,et al.  Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy , 2010 .

[90]  Z. Fayad,et al.  RGD peptide functionalized and reconstituted high‐density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  Angelique Louie,et al.  Multimodality imaging probes: design and challenges. , 2010, Chemical reviews.

[92]  Enzo Terreno,et al.  Challenges for molecular magnetic resonance imaging. , 2010, Chemical reviews.

[93]  V. Ntziachristos,et al.  Molecular imaging by means of multispectral optoacoustic tomography (MSOT). , 2010, Chemical reviews.

[94]  R. Weissleder,et al.  Hybrid PET-optical imaging using targeted probes , 2010, Proceedings of the National Academy of Sciences.

[95]  L. McManus,et al.  Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors. , 2010, Radiology.

[96]  T. Lammers Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations. , 2010, Advanced drug delivery reviews.

[97]  Zahi A Fayad,et al.  High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[98]  Vasilis Ntziachristos,et al.  Hybrid System for Simultaneous Fluorescence and X-Ray Computed Tomography , 2010, IEEE Transactions on Medical Imaging.

[99]  Xiang Li,et al.  Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery. , 2010, International journal of pharmaceutics.

[100]  Lihong V. Wang,et al.  Photoacoustic imaging and characterization of the microvasculature. , 2010, Journal of biomedical optics.

[101]  V. Zharov,et al.  Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents. , 2009, Nature nanotechnology.

[102]  Mark L Palmeri,et al.  Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism. , 2009, Ultrasound in medicine & biology.

[103]  Ralph Weissleder,et al.  18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. , 2009, JACC. Cardiovascular imaging.

[104]  Ralph Weissleder,et al.  Hybrid In Vivo FMT-CT Imaging of Protease Activity in Atherosclerosis With Customized Nanosensors , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[105]  Gemma Navarro,et al.  Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[106]  Liang Song,et al.  High-speed dynamic 3D photoacoustic imaging of sentinel lymph node in a murine model using an ultrasound array. , 2009, Medical physics.

[107]  Stanislav Emelianov,et al.  Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer. , 2009, Nano letters.

[108]  Zahi A Fayad,et al.  Nanotechnology in Medical Imaging: Probe Design and Applications , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[109]  Konstantin Sokolov,et al.  Plasmonic intravascular photoacoustic imaging for detection of macrophages in atherosclerotic plaques. , 2009, Nano letters.

[110]  Klaas Nicolay,et al.  Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. , 2009, Accounts of chemical research.

[111]  Oliver Thews,et al.  Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography. , 2009, Biomacromolecules.

[112]  A. Klibanov,et al.  Ultrasound triggered image-guided drug delivery. , 2009, European journal of radiology.

[113]  Younan Xia,et al.  Gold Nanocages: Synthesis, Properties, and Applications , 2009 .

[114]  J. Bulte,et al.  Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. , 2009, Cancer research.

[115]  D. Jaffray,et al.  Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model. , 2009, Molecular pharmaceutics.

[116]  Greg M Thurber,et al.  18F labeled nanoparticles for in vivo PET-CT imaging. , 2009, Bioconjugate chemistry.

[117]  Eric L. Miller,et al.  Hybrid FMT–CT imaging of amyloid-β plaques in a murine Alzheimer's disease model , 2009, NeuroImage.

[118]  H. Dai,et al.  Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery , 2009, Nano research.

[119]  Younan Xia,et al.  Near-infrared gold nanocages as a new class of tracers for photoacoustic sentinel lymph node mapping on a rat model. , 2009, Nano letters.

[120]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[121]  Zhuang Liu,et al.  Carbon nanotubes as photoacoustic molecular imaging agents in living mice. , 2008, Nature nanotechnology.

[122]  Donghoon Lee,et al.  Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. , 2008, Nanomedicine.

[123]  Chenjie Xu,et al.  PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.

[124]  C. R. Leemans,et al.  Improved tumor targeting of anti–epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology , 2008, Molecular Cancer Therapeutics.

[125]  Alexander L. Klibanov,et al.  Microbubbles in ultrasound-triggered drug and gene delivery. , 2008, Advanced drug delivery reviews.

[126]  Younan Xia,et al.  Gold nanocages: synthesis, properties, and applications. , 2008, Accounts of chemical research.

[127]  D. A. Capretto,et al.  Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors. , 2008, Cancer biotherapy & radiopharmaceuticals.

[128]  Z. Fayad,et al.  Nanomedicine captures cardiovascular disease. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[129]  Ciprian Catana,et al.  Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.

[130]  Jinming Gao,et al.  Theranostic nanomedicine for cancer. , 2008, Nanomedicine.

[131]  Donghoon Lee,et al.  In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.

[132]  Roel Deckers,et al.  The role of ultrasound and magnetic resonance in local drug delivery , 2008, Journal of magnetic resonance imaging : JMRI.

[133]  Xu Xiao Photoacoustic imaging in biomedicine , 2008 .

[134]  Xinmai Yang,et al.  Photoacoustic tomography of a rat cerebral cortex in vivo with au nanocages as an optical contrast agent. , 2007, Nano letters.

[135]  Weibo Cai,et al.  Nanoplatforms for targeted molecular imaging in living subjects. , 2007, Small.

[136]  V. Ntziachristos,et al.  Hybrid photoacoustic fluorescence molecular tomography using finite-element-based inversion. , 2007, Medical physics.

[137]  Klaas Nicolay,et al.  Magnetic Resonance Molecular Imaging Contrast Agents and Their Application in Atherosclerosis , 2007, Topics in Magnetic Resonance Imaging (TMRI).

[138]  Eric D. Pressly,et al.  Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers. , 2007, Biomacromolecules.

[139]  Sheng-Wen Huang,et al.  Targeted gold nanorod contrast agent for prostate cancer detection by photoacoustic imaging , 2007 .

[140]  Mark Borden,et al.  Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.

[141]  Zhong-gao Gao,et al.  Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. , 2007, Journal of the National Cancer Institute.

[142]  Michihiro Nakamura,et al.  Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles , 2007, International journal of cancer.

[143]  Klaas Nicolay,et al.  Magnetic and fluorescent nanoparticles for multimodality imaging. , 2007, Nanomedicine.

[144]  Matthew O'Donnell,et al.  Photoacoustic imaging of early inflammatory response using gold nanorods , 2007 .

[145]  Klaas Nicolay,et al.  MRI contrast agents: current status and future perspectives. , 2007, Anti-cancer agents in medicinal chemistry.

[146]  Anna Moore,et al.  In vivo imaging of siRNA delivery and silencing in tumors , 2007, Nature Medicine.

[147]  P. Oh,et al.  Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung , 2007, Nature Biotechnology.

[148]  K. Ulbrich,et al.  Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[149]  J. Sutcliffe,et al.  Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). , 2007, Nuclear medicine and biology.

[150]  Mark W Dewhirst,et al.  Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. , 2007, Journal of the National Cancer Institute.

[151]  S. Wise Nanocarriers as an emerging platform for cancer therapy , 2007 .

[152]  Katherine W Ferrara,et al.  Therapeutic effects of paclitaxel-containing ultrasound contrast agents. , 2006, Ultrasound in medicine & biology.

[153]  Shelton D Caruthers,et al.  Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. , 2006, Nanomedicine.

[154]  Patrick Winter,et al.  Nanomedicine Opportunities in Cardiology , 2006, Annals of the New York Academy of Sciences.

[155]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[156]  V. Ntziachristos Fluorescence molecular imaging. , 2006, Annual review of biomedical engineering.

[157]  Rebecca Richards-Kortum,et al.  Optical molecular imaging agents for cancer diagnostics and therapeutics. , 2006, Nanomedicine.

[158]  Raffi Bekeredjian,et al.  Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[159]  Florence Gazeau,et al.  Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. , 2006, Radiology.

[160]  Geng Ku,et al.  Noninvasive imaging of hemoglobin concentration and oxygenation in the rat brain using high-resolution photoacoustic tomography. , 2006, Journal of biomedical optics.

[161]  Klaas Nicolay,et al.  Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging , 2006, NMR in biomedicine.

[162]  Flemming Forsberg,et al.  Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging. , 2006, Ultrasound in medicine & biology.

[163]  K. Ulbrich,et al.  Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[164]  C. R. Leemans,et al.  (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[165]  Natalia Vykhodtseva,et al.  MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. , 2005, Ultrasound in medicine & biology.

[166]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[167]  Michael Reinhardt,et al.  Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. , 2005, Radiology.

[168]  C. Olbrich,et al.  Optical imaging in drug discovery and diagnostic applications. , 2005, Advanced drug delivery reviews.

[169]  Hui Zhang,et al.  Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. , 2005, Nano letters.

[170]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[171]  Lihong V. Wang,et al.  Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain , 2004 .

[172]  M. Bednarski,et al.  Molecular Imaging Applications in Nanomedicine , 2004, Biomedical microdevices.

[173]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[174]  Samuel A. Wickline,et al.  Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .

[175]  J. Frangioni In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[176]  R. Boellaard,et al.  Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[177]  Jonathan R. Lindner,et al.  Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to &agr;v&bgr;3 , 2003 .

[178]  Vasilis Ntziachristos,et al.  A submillimeter resolution fluorescence molecular imaging system for small animal imaging. , 2003, Medical physics.

[179]  A. Wunder,et al.  Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis1 , 2003, The Journal of Immunology.

[180]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[181]  S. Gambhir Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[182]  R. Weissleder,et al.  Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.

[183]  D. Kerr,et al.  Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[184]  R. Weissleder,et al.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.

[185]  S A Wickline,et al.  Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.

[186]  R. Weissleder,et al.  Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation. , 2001, Optics letters.

[187]  K. Kataoka,et al.  Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.

[188]  R. Vile,et al.  Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[189]  D. Miller,et al.  Diagnostic Ultrasound Activation of Contrast Agent Gas Bodies Induces Capillary Rupture in Mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[190]  M D Blaufox,et al.  PET imaging in oncology. , 2000, Seminars in nuclear medicine.

[191]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[192]  Koichi Ogawa,et al.  Induction of cell-membrane porosity by ultrasound , 1999, The Lancet.

[193]  T C Skalak,et al.  Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. , 1998, Circulation.

[194]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[195]  F. D. de Mul,et al.  Three-dimensional photoacoustic imaging of blood vessels in tissue. , 1998, Optics letters.